Cafusertib Hydrochloride

DRUG2 trials

Sponsors

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Conditions

Leukemia, Myeloid, AcuteNeoplasms

Phase 1

Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML)

Jiangsu Hansoh Pharmaceutical Co., Ltd.Leukemia, Myeloid, Acute

Start: 2014-05-31Updated: 2014-05-16

Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid Tumours

Jiangsu Hansoh Pharmaceutical Co., Ltd.Neoplasms

Start: 2014-11-30End: 2016-02-29Target: 40Updated: 2014-12-12